As those of you on the DXB forum know, DXB has been slow cooking for a while now. For me the buy signals were:
1. Very strong OBV.
2. Commencement of the current short term uptrend which in turn followed a retrace to the vicinity of the neckline after the initial breakout from the neckline.
The story is good, and will get better once Dimerix are in a position to introduce a sustained release form of propagermanium. Cutting out the middle of the day dosage should do wonders for patient compliance down the track.
Chartwatch - DXB
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
-0.025(4.13%) |
Mkt cap ! $318.8M | |||
| Open | High | Low | Value | Volume |
| 60.5¢ | 60.5¢ | 57.0¢ | $2.535M | 4.310M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17699 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
58.5¢ |
Change
-0.025 ( 2.50 %) |
||||
| Open | High | Low | Volume | ||
| 60.0¢ | 60.5¢ | 57.0¢ | 1977818 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| DXB (ASX) Chart |